Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8225927 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
Favorable-risk prostate cancer patients treated with a single implant HDR-BT to 24-27 Gy in two fractions within 1 day have excellent tolerance with minimal acute and chronic toxicity. Longer follow-up is needed to confirm these encouraging early results.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Michel M.D., Ph.D., Alvaro M.D., Gary M.D., Daniel M.D., J. Vito M.D., Peter M.D., James M.D., Michelle R.N., Hong M.S., Alyse R.N., Evelyn B.S., Leonard M.S., Amy B.S.,